雅虎香港 搜尋

搜尋結果

1. www.tandfonline.com › doi › pdfIntanza ® 9 µg intradermal seasonal influenza ...

   www.tandfonline.com › doi › pdf

   Intanza® 9 μg is considered satisfactory by at least 95% of both vaccinees and prescribers, especially because of the short needle and rapid administration. Because Intanza® 9 μg ofers an alternative to intramuscular vaccines, it might help increase influenza vaccine coverage rates.

2. www.ema.europa.eu › en › documentsINTANZA, INN-Influenza vaccine (split virion, inactivated) - ...

   www.ema.europa.eu › en › documents

   INTANZA is at least as immunogenic as the comparator trivalent inactivated influenza vaccine administered by intramuscular route for each of the 3 influenza strains in subjects from 60 years of age and over.

   • 檔案大小: 1MB

   • 頁面計數: 27

3. 其他人也問了

   What is intanza ®?

   • Vaccination is the primary method of prevention. Intanza (®) (Sanofi Pasteur, Lyon, France) is a newly licensed, trivalent, inactivated influenza vaccine that is delivered intradermally with a proprietary micoinjection system. Two dosage formulations have been approved for use in Europe and Australia.

   Intanza(®): a new intradermal vaccine for seasonal influenza

   pubmed.ncbi.nlm.nih.gov/21105776/

   查看此問題的所有搜尋結果

   Is intanza a new option for the prevention of influenza?

   • Intanza provides a new option for the prevention of influenza. Seasonal influenza causes annual epidemics in temperate climates and is associated with economic costs, morbidity and mortality. Vaccination is the primary method of prevention.

   Intanza(®): a new intradermal vaccine for seasonal influenza

   pubmed.ncbi.nlm.nih.gov/21105776/

   查看此問題的所有搜尋結果

   What is intanza ® 9 g (Sanofi Pasteur)?

   • substantial part of the socioeconomic burden of this disease. Intanza® 9 μg (sanofi pasteur) is a microneedle-delivered intradermal trivalent inactivated influenza vaccine approved in 2009 for the prevention of seasonal influenza in adults 18 to 59 y of age. The microneedle system reliably and reproducibly delivers the vaccine to the dermis.

   Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to

   www.tandfonline.com/doi/pdf/10.4161/hv.22342

   查看此問題的所有搜尋結果

   Who should use intanza?

   • Prophylaxis of influenza in individuals 60 years of age and over, especially in those who run an increased risk of associated complications. The use of Intanza should be based on official recommendations. How useful was this page?

   Intanza | European Medicines Agency

   www.ema.europa.eu/en/medicines/human/EPAR/intanza

   查看此問題的所有搜尋結果

4. europepmc.org › article › MEDIntanza (®) 9 µg intradermal seasonal influenza ...

   europepmc.org › article › MED

   • 網頁紀錄

   2013年1月1日 · Intanza 9 µg is considered satisfactory by at least 95% of both vaccinees and prescribers, especially because of the short needle and rapid administration. Because Intanza® 9 µg offers an alternative to intramuscular vaccines, it might help increase influenza vaccine coverage rates.

   • 作者: Isabel Leroux-Roels, Françoise Weber

   • Publish Year: 2013

5. pubmed.ncbi.nlm.nih.gov › 21105776Intanza(®): a new intradermal vaccine for seasonal influenza

   pubmed.ncbi.nlm.nih.gov › 21105776

   Seasonal influenza causes annual epidemics in temperate climates and is associated with economic costs, morbidity and mortality. Vaccination is the primary method of prevention. Intanza (®) (Sanofi Pasteur, Lyon, France) is a newly licensed, trivalent, inactivated influenza vaccine that is delivered ….

   • 作者: Robert L Atmar, Shital M Patel, Wendy A Keitel

   • Publish Year: 2010

6. www.ema.europa.eu › en › medicinesIntanza | European Medicines Agency

   www.ema.europa.eu › en › medicines

   • 網頁紀錄

   Intanza. Active substance. influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type) International non-proprietary ...

7. www.tandfonline.com › doi › fullIntanza®: a new intradermal vaccine for seasonal ...

   www.tandfonline.com › doi › full

   2014年1月9日 · Intanza ® (Sanofi Pasteur, Lyon, France) is a newly licensed, trivalent, inactivated influenza vaccine that is delivered intradermally with a proprietary micoinjection system. Two dosage formulations have been approved for use in Europe and Australia.

8. www.tandfonline.com › doi › fullFull article: Fluzone® intra-dermal (Intanza®/Istiva ...

   www.tandfonline.com › doi › full

   2016年8月3日 · Fluzone® ID and intanza®. An ID trivalent split-virion influenza vaccine (Fluzone® ID, Sanofi Pasteur, Swiftwater, PA) has been approved by the Food and Drug Administration (FDA) on 10 th May 2011 and been available in the US since the 2011/2012 influenza season for adults aged 18–64 y.